FGF2 Stimulates COUP-TFII Expression via the MEK1/2 Pathway to Inhibit Osteoblast Differentiation in C3H10T1/2 Cells

PLoS One. 2016 Jul 12;11(7):e0159234. doi: 10.1371/journal.pone.0159234. eCollection 2016.

Abstract

Chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) is an orphan nuclear receptor that regulates many key biological processes, including organ development and cell fate determination. Although the biological functions of COUP-TFII have been studied extensively, little is known about what regulates its gene expression, especially the role of inducible extracellular factors in triggering it. Here we report that COUP-TFII expression is regulated specifically by fibroblast growth factor 2 (FGF2), which mediates activation of the MEK1/2 pathway in mesenchymal lineage C3H10T1/2 cells. Although FGF2 treatment increased cell proliferation, the induction of COUP-TFII expression was dispensable. Instead, FGF2-primed cells in which COUP-TFII expression was induced showed a low potential for osteoblast differentiation, as evidenced by decreases in alkaline phosphatase activity and osteogenic marker gene expression. Reducing COUP-TFII by U0126 or siRNA against COUP-TFII prevented the anti-osteogenic effect of FGF2, indicating that COUP-TFII plays a key role in the FGF2-mediated determination of osteoblast differentiation capability. This report is the first to suggest that FGF2 is an extracellular inducer of COUP-TFII expression and may suppress the osteogenic potential of mesenchymal cells by inducing COUP-TFII expression prior to the onset of osteogenic differentiation.

MeSH terms

  • 3T3 Cells
  • Animals
  • COUP Transcription Factor II / genetics*
  • Cell Differentiation / drug effects*
  • Cell Lineage / drug effects
  • Cell Proliferation / drug effects
  • Extracellular Space / drug effects
  • Extracellular Space / metabolism
  • Fibroblast Growth Factor 2 / pharmacology*
  • Gene Expression Regulation / drug effects*
  • MAP Kinase Kinase 1 / metabolism*
  • MAP Kinase Kinase 2 / metabolism*
  • MAP Kinase Signaling System / drug effects
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects
  • Mice
  • Osteoblasts / cytology*
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism
  • Osteogenesis / drug effects
  • Time Factors

Substances

  • COUP Transcription Factor II
  • Fibroblast Growth Factor 2
  • MAP Kinase Kinase 1
  • MAP Kinase Kinase 2
  • Map2k2 protein, mouse

Grants and funding

This study was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (2011-0030121) and Chonnam National University Hospital Research Institute of Clinical Medicine (CRI 13905-21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.